Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1945 - 1952 of 11454 results
Healey Names Litigation Attorney Burrell As Campaign Manager
March 17, 2022| News
Connecticut Proposal to Cap Drug Price Increases Could Portend a Shift in the Drug Pricing Debate
March 17, 2022| Blog| Viewpoint
Utah Consumer Privacy Act – Mintz’s Hot Take
March 17, 2022| Blog| Viewpoint
OIG Issues Another Favorable Advisory Opinion on Treatment-Based Patient Incentives
March 15, 2022| Blog| Viewpoint
Stock Vesting in Startup Companies
March 15, 2022| Article| Viewpoint
EEOC (Again) Updates Religious Accommodation and Vaccine Mandate Guidance
March 14, 2022| Blog| Viewpoint
DOJ Keeps Focus on COVID-19 Related Fraud with Appointment of Director
March 14, 2022| Blog| Viewpoint
A Plan for East Boston is Great. But We Need One for Downtown...
March 11, 2022| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.